2008•Modern PathologyOpen access

High concordance between immunohistochemistry and fluorescence in situ hybridization testing for HER2 status in breast cancer requires a normalized IHC scoring system

Allen M. Gown, Lynn C. Goldstein, Todd S. Barry, Steven J. Kussick, Patricia L. Kandalaft, Patricia M Kim, Christopher C.H. Tse

Open full text 102 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 102 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Concordance, Immunohistochemistry, Fluorescence in situ hybridization, Breast cancer, In situ hybridization, Pathology, Medicine, In situ

Back to paper search Browse research topics Original source

High concordance between immunohistochemistry and fluorescence in situ hybridization testing for HER2 status in breast cancer requires a normalized IHC scoring system — Research Paper | ScholarLens